Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-01 · accession 0001765581-23-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-05 | 2023-06-01 | JAZZ | Patil Neena M | EVP, CLO | S - Sale | $127.98 | -1,600 | 32.9K | -5% | -$204.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-06-01 | S | D | 74 | $128.02 | 32,826 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-06-01 | S | D | 1,526 | $127.98 | 32,900 | D | — | — | (F1) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $127.91 to $128.015. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. (F2) Includes 87 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023. |